The Synthetic Chemistry Core facility will provide four basic services to this Program Project Grant (PPG).First, it will assist in the selection, prioritization and validation of primary hits identified from the efforts of theHTS Core for further chemical development. Second, the Core will provide synthetic servicesto includestructure-activity relationship (SAR) studies, scale-up of small molecules of interest for further pre-clinicalevaluation, synthesis of labeled compounds (isotopes, radioisotopes, and affinity labels), in addition togeneral synthetic services for intermediates and reagents not commerciallyavailable. A third service that willencompass the Synthetic Chemistry Core will be to provide analytical chemistry support to assist incompound identification, stability and solubility studies, metabolite identification (in collaboration with thePreclinical Pharmacology Core) and compound purity analysis. Finally, a continuous goal of the Core will beto establish a UTSW Compound Repository for the characterization, collection and submission of drug-likeintermediates and analogs synthesized by the Core for inclusion into the current HTS screening library tofuther enhance our library diversity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA095471-06
Application #
7315666
Study Section
Special Emphasis Panel (ZCA1-GRB-P (M1))
Project Start
2007-09-01
Project End
2012-07-31
Budget Start
2007-09-01
Budget End
2008-07-31
Support Year
6
Fiscal Year
2007
Total Cost
$512,934
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Qi, Chen; Wang, Xin; Shen, Zhirong et al. (2018) Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells. Cell Res 28:544-555
Zhang, Lu; Theodoropoulos, Panayotis C; Eskiocak, Ugur et al. (2016) Selective targeting of mutant adenomatous polyposis coli (APC) in colorectal cancer. Sci Transl Med 8:361ra140
Guo, Yirui; Scheuermann, Thomas H; Partch, Carrie L et al. (2015) Coiled-coil coactivators play a structural role mediating interactions in hypoxia-inducible factor heterodimerization. J Biol Chem 290:7707-21
Scheuermann, Thomas H; Stroud, Daniel; Sleet, Christopher E et al. (2015) Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2. J Med Chem 58:5930-41
Rose, Tristan E; Lawson, Kenneth V; Harran, Patrick G (2015) Large ring-forming alkylations provide facile access to composite macrocycles. Chem Sci 6:2219-2223
Zhang, Yongyou; Desai, Amar; Yang, Sung Yeun et al. (2015) TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348:aaa2340
Iscla, Irene; Wray, Robin; Wei, Shuguang et al. (2014) Streptomycin potency is dependent on MscL channel expression. Nat Commun 5:4891
Rogers, Jamie L; Bayeh, Liela; Scheuermann, Thomas H et al. (2013) Development of inhibitors of the PAS-B domain of the HIF-2ýý transcription factor. J Med Chem 56:1739-47
Wang, Changguang; Williams, Noelle S (2013) A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds. J Pharm Biomed Anal 75:112-7
Kilgore, Jessica A; Du, Xinlin; Melito, Lisa et al. (2013) Identification of DNMT1 selective antagonists using a novel scintillation proximity assay. J Biol Chem 288:19673-84

Showing the most recent 10 out of 67 publications